Page last updated: 2024-11-06

2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID43264
CHEMBL ID79720
SCHEMBL ID1370802
MeSH IDM0096111

Synonyms (18)

Synonym
CHEMBL79720 ,
2,4,6-cycloheptatrien-1-one, 2-methoxy-5-(2,3,4-trimethoxyphenyl)-
2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone
brn 4324860
nsc-367601
nsc367601
60423-21-4
2-methoxy-5-(2,3,4-trimethoxyphenyl)cyclohepta-2,4,6-trien-1-one
2-methoxy-5-(2,3,4-trimethoxyphenyl)-
2-methoxy-5-(2,3,4-trimethoxy-phenyl)-cyclohepta-2,4,6-trienone
bdbm50279934
2-methoxy-5-(2,3,4-trimethoxyphenyl)-2,4,6-cycloheptatrien-1-one
nsc 367601
unii-xlq3sgl8dp
xlq3sgl8dp ,
SCHEMBL1370802
DTXSID40209176
8wb ,
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID288670Displacement of MTC from tubulin2007Journal of medicinal chemistry, Jun-14, Volume: 50, Issue:12
Arylthioindole inhibitors of tubulin polymerization. 3. Biological evaluation, structure-activity relationships and molecular modeling studies.
AID1178971Immunosuppressive activity in B cells (unknown origin) assessed as inhibition of LPS-induced cell proliferation at 3 to 30 ng/mL2014Bioorganic & medicinal chemistry letters, Jul-15, Volume: 24, Issue:14
Discovery of structurally simplified analogs of colchicine as an immunosuppressant.
AID1178972Immunosuppressive activity in T cells (unknown origin) assessed as inhibition of Con A-induced cell proliferation at 3 to 30 ng/mL2014Bioorganic & medicinal chemistry letters, Jul-15, Volume: 24, Issue:14
Discovery of structurally simplified analogs of colchicine as an immunosuppressant.
AID1714650Binding affinity to calf brain tubulin assessed as compound-protein complex stoichiometry ratio of 1:1 in absence of Mg2+ by spectrofluorometry analysis2018Journal of natural products, 03-23, Volume: 81, Issue:3
Zampanolide Binding to Tubulin Indicates Cross-Talk of Taxane Site with Colchicine and Nucleotide Sites.
AID1714649Binding affinity to zampanolide-modified calf brain tubulin2018Journal of natural products, 03-23, Volume: 81, Issue:3
Zampanolide Binding to Tubulin Indicates Cross-Talk of Taxane Site with Colchicine and Nucleotide Sites.
AID1714651Binding affinity to zampanolide-modified calf brain tubulin assessed as compound-protein complex stoichiometry ratio of 1:1 in absence of Mg2+ by spectrofluorometry assay2018Journal of natural products, 03-23, Volume: 81, Issue:3
Zampanolide Binding to Tubulin Indicates Cross-Talk of Taxane Site with Colchicine and Nucleotide Sites.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (36.67)18.7374
1990's10 (33.33)18.2507
2000's5 (16.67)29.6817
2010's3 (10.00)24.3611
2020's1 (3.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.04 (24.57)
Research Supply Index3.47 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.23%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (96.77%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]